首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺癌脑转移放疗疗效分析
引用本文:王飞江,李枫,朱向帜.肺癌脑转移放疗疗效分析[J].临床神经外科杂志,2011,8(5):267-268.
作者姓名:王飞江  李枫  朱向帜
作者单位:江苏省肿瘤医院放疗科, 南京,210009
摘    要:目的 对肺癌脑转移全脑放疗局部加量的疗效进行分析.方法 回顾性分析51例肺癌脑转移患者全脑放疗局部加量的治疗效果.结果 中位总生存时间11个月.单因素分析显示脑转移灶总刺量,颅外转移,RPA分级与总生存有关.多因素分析显示总剂量,颅外转移和RPA分级是独立预后因素.结论 全脑放疗局部加量的方式对于RPA分级为1~2级...

关 键 词:肺癌  脑转移  全脑放疗  预后

Curative effect of radiotherapy in patients with brain metastasis from lung cancer
WANG Fei-jiang,LI Feng,ZHU Xiang-zhi.Curative effect of radiotherapy in patients with brain metastasis from lung cancer[J].Journal of Clinical Neurosurgery,2011,8(5):267-268.
Authors:WANG Fei-jiang  LI Feng  ZHU Xiang-zhi
Institution:. Department of Radiotherapy, Jiangsu Cancer Hospital. Nanjing 210009, China
Abstract:Objective To analyze the curative effect of brain metastasis from lung cancer applied with an external beam radiotherapy boost after whole brain radiotherapy. Methods The clinical data of 51 patients with brain metastasis from lung cancer treated sequentially with whole brain therapy and radiotherapy boost, were analyzed retrospectively. Result The median overall survival time was 11 months. On univariate analysis, improved OS was found to be significantly related with total dose of brain metastasis site, extracranial metastasis and RPA. On multivariate analysis, total dose of brain metastasis site, extracranial metastasis and RPA were independent prognostic factors. Conclusions There might be a group of patients with RPA 1-2 and no extracranial disease who may benefit from dose escalation after WBRT to the metastatic site.
Keywords:lung cancer brain metastasis whole brain radiotherapy prognosis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号